Skip to content

Drug interactions

Deflazacort + Fedratinib

Severity: Moderate

Deflazacort and Fedratinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fedratinib is a moderate CYP3A4 inhibitor and may increase exposure to the active metabolite of deflazacort. This can intensify corticosteroid adverse effects such as hyperglycemia, fluid retention and infection.

What this interaction means in plain words

Deflazacort and Fedratinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Deflazacort belongs to Miscellaneous; Fedratinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Fedratinib inhibits CYP3A4, reducing the metabolic clearance of the active deflazacort metabolite.

What to do

Reduce the deflazacort dose to about one-third of the usual dose during coadministration, consistent with guidance for moderate CYP3A4 inhibitors. Monitor for glucocorticoid excess.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deflazacort and Fedratinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Deflazacort with Fedratinib?

MediHelp rates the interaction as moderate. Deflazacort and Fedratinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Fedratinib is a moderate CYP3A4 inhibitor and may increase exposure to the active metabolite of deflazacort. This can intensify corticosteroid adverse effects such as hyperglycemia, fluid retention and infection.

How serious is the interaction between Deflazacort and Fedratinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce the deflazacort dose to about one-third of the usual dose during coadministration, consistent with guidance for moderate CYP3A4 inhibitors. Monitor for glucocorticoid excess.

What other medicines interact with Deflazacort?

MediHelp also lists interactions of Deflazacort with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Deflazacort page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in